You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-heavy chain Myosin antibody [RNMy2/9D2] (ab49457)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-heavy chain Myosin antibody [RNMy2/9D2]
See all heavy chain Myosin products (5) ...

Description

Mouse monoclonal [RNMy2/9D2] to heavy chain Myosin

Specificity

Human myosin developmental type heavy chain. Note that this antibody recognises a myosin heavy chain (MHC) present during the embryonic and neonatal period in the development of skeletal muscle. The same MHC occurs during regeneration of muscle fibres

Tested applications

IHC-Frmore details

Cross reactivity

Reacts with

Rat, Human

Immunogen

Native myosin extracted from the hind limb muscle of 7 day old rats.

Positive control

Immunohistochemistry - Myosin heavy chain found during the neonatal period in rat muscle and during the foetal period in human muscle.

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 15mM Sodium Azide
Constituents: Tissue culture supernatant

Purity

Tissue culture supernatant

Clonality

Monoclonal

Clone number

RNMy2/9D2

Myeloma

x63-Ag8.653

Isotype

IgG1

Applications

Show applications key

Our Abpromise guarantee covers the use of ab49457 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • IHC-Fr

     

Application notes

IHC-Fr: 1/10 - 1/40. Indirect immunoperoxidase technique.

Is unsuitable for IHC-P.


Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Muscle contraction.

Involvement in disease

Defects in MYH3 are the cause of distal arthrogryposis type 2A (DA2A) [MIM:193700]; also known as Freeman-Sheldon syndrome (FSS). Distal arthrogryposis is a clinically and genetically heterogeneous group of disorders characterized by bone anomalies and joint contractures of the hands and feet, causing medially overlapping fingers, clenched fists, ulnar deviation of fingers, camptodactyly and positional foot deformities. It is a disorder of primary limb malformation without primary neurologic or muscle disease. DA2A is the most severe form of distal arthrogryposis. Affected individuals have contractures of the orofacial muscles, characterized by microstomia with pouting lips, H-shaped dimpling of the chin, deep nasolabial folds, and blepharophimosis. Dysphagia, failure to thrive, growth deficit, and life-threatening respiratory complications (caused by structural anomalies of the oropharynx and upper airways) are frequent. Inheritance is autosomal dominant.
Defects in MYH3 are the cause of distal arthrogryposis type 2B (DA2B) [MIM:601680]; also known as Sheldon-Hall syndrome (SHS) or arthrogryposis multiplex congenita distal type 2B (AMCD2B). DA2B is a form of inherited multiple congenital contractures. Affected individuals have vertical talus, ulnar deviation in the hands, severe camptodactyly, and a distinctive face characterized by a triangular shape, prominent nasolabial folds, small mouth and a prominent chin. DA2B is the most common of the distal arthrogryposis syndromes. It is similar to DA2A but the facial contractures are less dramatic.

Sequence similarities

Contains 1 IQ domain.
Contains 1 myosin head-like domain.

Developmental stage

Abundantly present in fetal skeletal muscle and not present or barely detectable in heart and adult skeletal muscle.

Domain

The rodlike tail sequence is highly repetitive, showing cycles of a 28-residue repeat pattern composed of 4 heptapeptides, characteristic for alpha-helical coiled coils.
Each myosin heavy chain can be split into 1 light meromyosin (LMM) and 1 heavy meromyosin (HMM). It can later be split further into 2 globular subfragments (S1) and 1 rod-shaped subfragment (S2).

Cellular localization

Cytoplasm > myofibril. Thick filaments of the myofibrils.

Target information above from: UniProt accessionP11055 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • embryonic antibody
  • fast skeletal muscle antibody
  • HEMHC antibody
  • Muscle embryonic myosin heavy chain 3 antibody
  • Muscle embryonic myosin heavy chain antibody
  • MYH 3 antibody
  • MYH3 antibody
  • MYH3_HUMAN antibody
  • MYHC EMB antibody
  • MYHSE 1 antibody
  • MYHSE1 antibody
  • Myosin heavy chain 3 antibody
  • Myosin heavy chain 3 skeletal muscle embryonic antibody
  • Myosin heavy chain antibody
  • Myosin heavy chain fast skeletal muscle embryonic antibody
  • Myosin Heavy Polypeptide 3 antibody
  • Myosin heavy polypeptide 3 skeletal muscle embryonic antibody
  • Myosin skeletal heavy chain embryonic 1 antibody
  • Myosin-3 antibody
  • SMHCE antibody
see all

References for Anti-heavy chain Myosin antibody [RNMy2/9D2] (ab49457)

This product has been referenced in:

  • Bigard AXet al. Changes in myosin heavy chain profile of mature regenerated muscle with endurance training in rat. Acta Physiol Scand 165:185-92 (1999).Read more (PubMed: 10090330) »
  • Lepper Cet al. An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 138:3639-46 (2011).Read more (PubMed: 21828092) »

See all 2 publications for this product

Publishing research using ab49457? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"